Drug intelligence / Profile preview

amino acid peritoneal dialysis solution

Development stage
Phase 4
Lead developer
Baxter Healthcare Corporation
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Intraperitoneal
01

Overview

Amino acid peritoneal dialysis solutions are specialized intraperitoneal fluids used in patients undergoing peritoneal dialysis, particularly those with protein malnutrition. These solutions contain a mixture of essential and non-essential amino acids (such as histidine, valine, isoleucine, alanine, leucine, arginine, lysine, glycine, methionine, proline, phenylalanine, serine, threonine, tyrosine and tryptophan) formulated to compensate for protein losses during dialysis and to provide a source of nutrition when dietary intake is insufficient[4][5]. The mechanism of action involves the absorption of amino acids from the dialysate into the bloodstream through the peritoneum; this stimulates protein synthesis and inhibits protein breakdown—mimicking an anabolic response similar to food intake[1][2]. These solutions may be used alone or in combination with glucose-containing dialysates to optimize both caloric and protein delivery. They are indicated for treating or preventing malnutrition in chronic kidney disease patients on continuous ambulatory or automated peritoneal dialysis who cannot meet nutritional requirements through diet alone[4][5].

Brand names
Nutrineal PD4
Other names
amino acid-based peritoneal dialysis solutionAA-based dialysate1.1% amino acid peritoneal dialysis solution
02

Targets

SERPINA1 (Alpha-1-antitrypsin)

Beyond the preview

Go deeper on amino acid peritoneal dialysis solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amino acid peritoneal dialysis solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call